1. Home
  2. FRGE vs PROC Comparison

FRGE vs PROC Comparison

Compare FRGE & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRGE
  • PROC
  • Stock Information
  • Founded
  • FRGE 2014
  • PROC 1976
  • Country
  • FRGE United States
  • PROC Luxembourg
  • Employees
  • FRGE N/A
  • PROC N/A
  • Industry
  • FRGE Computer Software: Prepackaged Software
  • PROC Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRGE Technology
  • PROC Health Care
  • Exchange
  • FRGE Nasdaq
  • PROC Nasdaq
  • Market Cap
  • FRGE 196.1M
  • PROC 203.1M
  • IPO Year
  • FRGE N/A
  • PROC N/A
  • Fundamental
  • Price
  • FRGE $0.94
  • PROC $2.55
  • Analyst Decision
  • FRGE Strong Buy
  • PROC
  • Analyst Count
  • FRGE 3
  • PROC 0
  • Target Price
  • FRGE $4.50
  • PROC N/A
  • AVG Volume (30 Days)
  • FRGE 710.3K
  • PROC 136.8K
  • Earning Date
  • FRGE 11-06-2024
  • PROC 02-15-2025
  • Dividend Yield
  • FRGE N/A
  • PROC N/A
  • EPS Growth
  • FRGE N/A
  • PROC N/A
  • EPS
  • FRGE N/A
  • PROC 0.52
  • Revenue
  • FRGE $79,799,000.00
  • PROC $414,096,000.00
  • Revenue This Year
  • FRGE $19.18
  • PROC $5.54
  • Revenue Next Year
  • FRGE $34.32
  • PROC $8.54
  • P/E Ratio
  • FRGE N/A
  • PROC $4.87
  • Revenue Growth
  • FRGE 18.08
  • PROC N/A
  • 52 Week Low
  • FRGE $0.80
  • PROC $0.50
  • 52 Week High
  • FRGE $4.02
  • PROC $4.95
  • Technical
  • Relative Strength Index (RSI)
  • FRGE 39.86
  • PROC 57.57
  • Support Level
  • FRGE $0.90
  • PROC $2.40
  • Resistance Level
  • FRGE $1.25
  • PROC $3.78
  • Average True Range (ATR)
  • FRGE 0.09
  • PROC 0.46
  • MACD
  • FRGE -0.01
  • PROC 0.09
  • Stochastic Oscillator
  • FRGE 2.14
  • PROC 55.63

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The Company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

About PROC Procaps Group S.A.

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Share on Social Networks: